InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the complete record of transactions filed by Quimi Daphne, Chief Financial Officer. Officer active across 1 company, notably Amicus Therapeutics, INC.. Cumulatively, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €38k. History available since 31 December 2021. The latest transaction was filed on 17 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
4,396 shares@ US$9.000.0008% mcap14.9% of flowCommon StockSEC:0001209191-22-038365:0
36,840 sharesCommon StockSEC:0001209191-22-003818:0
36,840 sharesCommon StockSEC:0001209191-22-003818
10,502 shares@ US$11.550.0024% mcap42.5% of flowCommon StockSEC:0001209191-22-001205:0
10,502 shares@ US$11.550.0024% mcap100.0% of flowCommon StockSEC:0001209191-22-001205
5 of 5 declarations
About Quimi Daphne
Daphne Quimi serves as Chief Financial Officer of AMICUS THERAPEUTICS, INC. She is responsible for managing the company's finances, including financial planning, risk management, and regulatory compliance. Quimi plays a key role in developing financial strategies that support the growth and profitability of AMICUS THERAPEUTICS.
